CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion | +73,704 | 73,704 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion | +5,774 | 79,478 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series A-1 Preferred Shares | −437,247 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series A-1 Preferred Shares | −2,754 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series A-2 Preferred Shares | −3,100,477 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series A-2 Preferred Shares | −19,524 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series A-3 Preferred Shares | −2,210,417 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series A-3 Preferred Shares | −66,490 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series A-3 Preferred Shares | −168,224 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series A-3 Preferred Shares | −73,704 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series B Preferred Shares | −231,077 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series B Preferred Shares | −1,454 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series B Preferred Shares | −173,167 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series B Preferred Shares | −5,210 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series B Preferred Shares | −13,180 | 0 | ||
| 2016-10-24 | Bolzon Bradley J PhD Director | Conversion · Series B Preferred Shares | −5,774 | 0 | ||
| 2016-10-24 | CELGENE CORP /DE/ 10% owner | Conversion | +4,034,830 | 4,034,830 | ||
| 2016-10-24 | CELGENE CORP /DE/ 10% owner | Purchase | +800,150 | $14.00 | $11.2M | 4,834,980 |
| 2016-10-24 | CELGENE CORP /DE/ 10% owner | Conversion · Series B Preferred Shares | −4,034,830 | 0 | ||
| 2016-10-24 | CELGENE CORP /DE/ 10% owner | Conversion | +4,034,830 | 4,034,830 |
Page 72 of 74 · 1,471 trades